Deciphering mechanisms of perivascular tumor cell invasion in glioblastoma

破译胶质母细胞瘤血管周围肿瘤细胞侵袭的机制

• 批准号: 8851692
• 负责人: Joseph H McCarty
• 金额: $ 38.44万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-15 至 2016-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8851692
• 关键词: Ablation; Address; Adenoviruses; Adhesions; Avastin; Basement membrane; Blocking Antibodies; Blood Vessels; Brain; Brain Neoplasms; Cell Polarity; Cell-Cell Adhesion; Cells; Cerebrum; Coculture Techniques; Coupled; Data; Defect; Development; Endothelial Cells; Event; Extracellular Matrix; Extracellular Matrix Proteins; Gene Expression; Genetic; Glioblastoma; Growth; Health; Human; Immunodeficient Mouse; Implant; Infiltration; Integrin Inhibition; Integrins; Lead; Lesion; Ligands; Link; Malignant - descriptor; Malignant Neoplasms; Malignant neoplasm of brain; Mediating; Modeling; Molecular; Molecular Genetics; Mus; Neuroglia; Neurons; Neuropilin-1; Pathology; Pathway interactions; Patients; Perivascular Neoplasm; Physiology; Pre-Clinical Model; Primary Brain Neoplasms; Property; Proteins; RNA Interference; Role; Sampling; Signal Pathway; Signal Transduction; System; Testing; Transforming Growth Factor beta; Transforming Growth Factors; Tumor Cell Invasion; Vascular Endothelial Growth Factor Receptor; Vascular Endothelial Growth Factors; Work; Xenograft procedure; antiangiogenesis therapy; autocrine; base; bevacizumab; cell growth; cell motility; cell type; design; migration; mouse model; multidisciplinary; neoplastic cell; nerve stem cell; novel; novel therapeutics; pre-clinical; receptor; research study; response; stem; therapeutic angiogenesis; tool; tumor initiation; tumor progression

DESCRIPTION (provided by applicant): Glioblastoma multiformes (GBMs) are primary brain tumors displaying invasive growth properties that are tightly coupled to the vasculature. For example, stem-like GBM cells preferentially cluster in perivascular niches and invasive GBM cells often disperse throughout the brain via vascular basement membranes. Furthermore, anti-angiogenesis therapies administered to patients with GBM often lead to enhanced tumor cell infiltration and the formation of lethal satellite lesions. The molecular mechanisms that couple GBM cells to cerebral blood vessels during tumor progression and following anti-angiogenesis therapies remain largely unknown. In this project we will investigate how GBM cells exploit a specific cell adhesion and signaling axis comprised of αvβ8 integrin, its latent TGFβ extracellular matrix (ECM) protein ligands, and TGFβ receptors to selectively promote perivascular growth and dispersal in the brain. We have discovered that αvβ8 integrin is expressed in invasive GBM cells where it mediates activation of TGFβs to drive cell polarity and directional migration. In addition, αvβ8 integrin protein is highly expressed in invasive GBM cells following anti-angiogenesis treatments. Based on these data we hypothesize that αvβ8 integrin regulates adhesion and signaling pathways that promote GBM cell invasion during tumor progression and following anti-vascular therapies. Furthermore, we hypothesize that inhibiting components of these pathways will diminish GBM cell infiltration. To test our hypotheses we have developed a unique set of experimental tools to (1) characterize how αvβ8 integrin interacts with the VEGF-A receptor Neuropilin-1 to promote GBM cell infiltration; (2) investigate how integrin-activated TGFβs cooperate with VEGF-A to drive GBM cell invasiveness; and (3) selectively inhibit components of these pathways to block invasiveness in pre-clinical mouse models of GBM. Collectively, these experiments will not only elucidate novel links between αvβ8 integrin-activated TGFβs and VEGF-A receptors in GBM cells, but may eventually lead to new therapeutic strategies for inhibiting cell invasion during tumor progression and following anti-vascular therapies.

描述（由申请人提供）：多形性胶质母细胞瘤（GBM）是一种原发性脑肿瘤，显示出与血管系统紧密结合的侵袭性生长特性。例如，干细胞样GBM细胞优先聚集在血管周围的壁龛中，侵袭性GBM细胞通常通过血管基底膜分散在整个脑中。此外，给予GBM患者的抗血管生成疗法通常导致增强的肿瘤细胞浸润和形成致命的卫星病变。在肿瘤进展过程中和抗血管生成治疗后，将GBM细胞与脑血管偶联的分子机制在很大程度上仍然未知。在这个项目中，我们将研究GBM细胞如何利用由αvβ8整联蛋白、其潜在的TGFβ细胞外基质（ECM）蛋白配体和TGFβ受体组成的特异性细胞粘附和信号传导轴来选择性地促进脑中血管周围的生长和扩散。我们已经发现αvβ8整合素在侵袭性GBM细胞中表达，在那里它介导TGFβs的活化以驱动细胞极性和定向迁移。此外，αvβ8整联蛋白在抗血管生成治疗后的侵袭性GBM细胞中高度表达。基于这些数据，我们假设αvβ8整联蛋白调节粘附和信号通路，促进肿瘤进展期间和抗血管治疗后的GBM细胞侵袭。此外，我们假设抑制这些途径的成分将减少GBM细胞浸润。为了验证我们的假设，我们开发了一套独特的实验工具，以（1）表征αvβ8整合素如何与VEGF-A受体Neuropilin-1相互作用以促进GBM细胞浸润;（2）研究整合素活化的TGFβ如何与VEGF-A合作以驱动GBM细胞侵袭;和（3）选择性抑制这些途径的组分以阻断GBM临床前小鼠模型中的侵袭。总的来说，这些实验不仅将阐明GBM细胞中αvβ8整合素激活的TGFβs和VEGF-A受体之间的新联系，而且最终可能导致在肿瘤进展期间抑制细胞侵袭的新治疗策略 和抗血管治疗后。